Sanford C. Bernstein Upgrades agilon health (NYSE:AGL) to “Outperform”

agilon health (NYSE:AGL) was upgraded by investment analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating in a research note issued on Tuesday, MarketBeat.com reports. The firm currently has a $8.50 price objective on the stock, up from their previous price objective of $3.30. Sanford C. Bernstein’s price objective indicates a potential upside of 64.09% from the stock’s previous close.

Other analysts also recently issued research reports about the company. Stifel Nicolaus upped their target price on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research note on Wednesday, February 26th. Needham & Company LLC reaffirmed a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Macquarie began coverage on shares of agilon health in a report on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and raised their price target for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Finally, Royal Bank of Canada upped their price objective on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research report on Wednesday, February 26th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $4.37.

agilon health Price Performance

Shares of NYSE:AGL opened at $5.18 on Tuesday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a twelve month low of $1.50 and a twelve month high of $7.73. The company’s 50 day moving average is $3.90 and its 200 day moving average is $3.05. The company has a market cap of $2.14 billion, a PE ratio of -5.51 and a beta of 0.38.

Institutional Investors Weigh In On agilon health

A number of large investors have recently modified their holdings of AGL. Captrust Financial Advisors grew its stake in agilon health by 10.9% during the 4th quarter. Captrust Financial Advisors now owns 35,485 shares of the company’s stock valued at $67,000 after acquiring an additional 3,494 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of agilon health by 2.5% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company’s stock valued at $393,000 after purchasing an additional 5,107 shares in the last quarter. MetLife Investment Management LLC increased its holdings in shares of agilon health by 4.0% in the fourth quarter. MetLife Investment Management LLC now owns 174,551 shares of the company’s stock valued at $332,000 after purchasing an additional 6,762 shares during the last quarter. Symphony Financial Services Inc. lifted its position in agilon health by 44.3% during the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock worth $44,000 after buying an additional 7,058 shares in the last quarter. Finally, Signaturefd LLC lifted its position in agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after buying an additional 8,467 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.